Details of the Drug Formulaction

General Information of Drug Formulation (ID: F07992)

• Formulation Name: Fenofibrate 160 mg tablet
• Company: Aphena Pharma Solutions-Tennessee; Mylan Pharamceuticals

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Fenofibrate	(DMFKXDY)	Coronary atherosclerosis		Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Brushite	(E00392)	104805	Diluent
Docusate sodium	(E00563)	23673837	Surfactant
Magnesium stearate	(E00208)	11177	lubricant
Polysorbate 80	(E00665)	Not Available	Dispersing agent; Emollient; Emulsifying agent; Plasticizing agent; Solubilizing agent; Surfactant; Suspending agent
Silicon dioxide	(E00670)	Not Available	Anticaking agent; Opacifying agent; Viscosity-controlling agent
Sodium benzoate	(E00432)	517055	Antimicrobial preservative; lubricant
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent